Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davidson

Showing results (161-170 of 358) with videos related to

Pageof 36
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 26, 2006
Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expressionStine Sivertsen, Rivka Hadar, Sivan Elloul, et al.
Gynecologic Oncology|August 6, 2014
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusionsAna Slipicevic, Arild Holth, Ellen Hellesylt, et al.
Human Pathology|November 2, 2015
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusionsBen Davidson, Helene Tuft Stavnes, Ellen Hellesylt, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 7, 2017
Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumorsOlesya Solheim, Mette Førsund, Claes G Tropé, et al.
Human Pathology|December 8, 2015
HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survivalBen Davidson, Arild Holth, Ellen Hellesylt, et al.
Cell Reports|January 1, 2013
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1Vered Ben-Hur, Polina Denichenko, Zahava Siegfried, et al.
Cancer Letters|February 18, 2014
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcomaFrancesca Micci, Ludmila Gorunova, Sonia Gatius, et al.
Oncotarget|April 21, 2017
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expressionAntonio Agostini, Marta Brunetti, Ben Davidson, et al.
Gynecologic Oncology|July 21, 2004
Kallikrein 4 is associated with paclitaxel resistance in ovarian cancerZhijun Xi, Janne Kaern, Ben Davidson, et al.
Gynecologic Oncology|May 29, 2018
Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinomaBen Davidson, Marianne Bjørnerem, Arild Holth, et al.
Pageof 36

Showing results (161-170 of 358) with videos related to

Sort By:
Pageof 36
Lung Cancer (Amsterdam, Netherlands)|September 26, 2006
Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expressionStine Sivertsen, Rivka Hadar, Sivan Elloul, et al.
Gynecologic Oncology|August 6, 2014
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusionsAna Slipicevic, Arild Holth, Ellen Hellesylt, et al.
Human Pathology|November 2, 2015
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusionsBen Davidson, Helene Tuft Stavnes, Ellen Hellesylt, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 7, 2017
Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumorsOlesya Solheim, Mette Førsund, Claes G Tropé, et al.
Human Pathology|December 8, 2015
HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survivalBen Davidson, Arild Holth, Ellen Hellesylt, et al.
Cell Reports|January 1, 2013
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1Vered Ben-Hur, Polina Denichenko, Zahava Siegfried, et al.
Cancer Letters|February 18, 2014
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcomaFrancesca Micci, Ludmila Gorunova, Sonia Gatius, et al.
Oncotarget|April 21, 2017
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expressionAntonio Agostini, Marta Brunetti, Ben Davidson, et al.
Gynecologic Oncology|July 21, 2004
Kallikrein 4 is associated with paclitaxel resistance in ovarian cancerZhijun Xi, Janne Kaern, Ben Davidson, et al.
Gynecologic Oncology|May 29, 2018
Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinomaBen Davidson, Marianne Bjørnerem, Arild Holth, et al.
Pageof 36